Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Manchester Featured PhD Programmes
Swansea University Featured PhD Programmes
University of Oxford Featured PhD Programmes
University of Oxford Featured PhD Programmes
Max Planck Society Featured PhD Programmes

Molecular Biology of Antiviral Signalling in the CRISPR system

  • Full or part time
    Prof M F White
  • Application Deadline
    Monday, January 07, 2019
  • Competition Funded PhD Project (Students Worldwide)
    Competition Funded PhD Project (Students Worldwide)

Project Description

CRISPR is a prokaryotic adaptive immune system that has been harnessed for a wide range of genome engineering, synthetic biology, biotechnology and healthcare applications. This project will focus on the Type III CRISPR system which is more complex than Cas9, consisting of a large ribonucleoprotein machine that detects tiny amounts of viral RNA and unleashes an array of defensive enzymes that target and degrade invading genetic entities. In 2017, this system was shown to generate a completely novel type of ring-shaped signalling molecule, cyclic oligoadenylate (cOA). Although this is a powerful immune defence, it must be tightly controlled to avoid killing the host. Recently we showed how the system is controlled in the model organism Sulfolobus solfataricus (Rouillon et al., eLife, 2018) and discovered a novel class of enzymes that degrades the signalling molecule to switch off the antiviral state (Athukoralage et al., Nature 2018).

Many aspects of the Type III CRISPR system remain to be discovered. In this project, you will focus on cellular response to the cOA signalling molecule, which binds to and activates a range of proteins including nucleases and transcription factors. We are working with collaborators in London and the USA to characterise this signalling system both in vitro and in vivo, and there will be possibilities for lab exchanges with our partners.

You will have a degree in the broad area of the Life Sciences and an interest in the molecular biology of the CRISPR system. We will provide opportunities for training in a wide range of cutting-edge technologies including molecular biology, biochemistry and microbiology. You will join a well-funded and friendly lab with good technical support, occupying new, purpose-built lab space in the Biomedical Sciences Research Complex at St Andrews. For more information or informal enquiries, please contact Prof Malcolm White ().

Funding Notes

This funding opportunity is now only available to Chinese nationals who are applying through the Chinese Scholarship Council.

All other applicants who applied before the 2 December deadline are currently under consideration.

References

Athukoralage, J. S., Rouillon, C., Graham, S., Grüschow, S., & White, M. F. (2018). Ring nucleases deactivate Type III CRISPR ribonucleases by degrading cyclic oligoadenylate. Nature doi:10.1038/s41586-018-0557-5

Rouillon, C., Athukoralage, J. S., Graham, S., Grüschow, S., & White, M. F. (2018). Control of cyclic oligoadenylate synthesis in a type III CRISPR system. Elife, 7, e36734.

Related Subjects

How good is research at University of St Andrews in Biological Sciences?

FTE Category A staff submitted: 50.45

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2018
All rights reserved.